Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-07-16
Summary
The goal of this observational study is to investigate the real-world treatment landscape of patients with metastatic cancer and determine the role of ctDNA in monitoring treatment response in patients with metastatic cancer who have undergone K4Care testing
Conditions
- Metastatic Cancers
Sponsors & Collaborators
-
The Medical Genetics Institute (MGI) of HCMC
collaborator UNKNOWN -
Gene Solutions
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-09
- Primary Completion
- 2026-12-31
- Completion
- 2027-06-30
Countries
- Vietnam
Study Locations
More Related Trials
-
Multi-Cancer Detection Observational Cohort Study
NCT06962995 ·Status: RECRUITING
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
NCT05227261 ·Status: COMPLETED
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy
NCT02133222 ·Status: COMPLETED ·Phase: NA
-
Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
NCT06877910 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of G-quadruplex DNA Methylation in Cancer
NCT06537063 ·Status: WITHDRAWN
-
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
NCT00899548 ·Status: COMPLETED
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
NCT06589388 ·Status: RECRUITING
-
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
NCT01772771 ·Status: RECRUITING
-
Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)
NCT05116579 ·Status: RECRUITING
-
Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis
NCT03029065 ·Status: UNKNOWN
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
NCT05029869 ·Status: ACTIVE_NOT_RECRUITING
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration
NCT05882292 ·Status: RECRUITING ·Phase: PHASE2
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
NCT06653127 ·Status: RECRUITING
-
Multi-analyte Blood Test Clinical Trial
NCT05199259 ·Status: RECRUITING
-
Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation
NCT02412579 ·Status: COMPLETED